首頁 > 市場調查報告書 > 材料/化學品

市場調查報告書

商品編碼

1843395

2021-2031 年北美類器官服務市場報告（範圍、細分、動態和競爭分析）

North America Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年08月14日 | 出版商:

The Insight Partners | 英文 121 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美類器官服務市場預計將大幅成長，到 2031 年將達到約 65.7444 億美元，高於 2024 年的 16.4088 億美元，在此期間複合年複合成長率(CAGR) 高達 21.9%。

執行摘要和市場分析

市場分為三個主要區域：美國、加拿大和墨西哥，預計美國將在 2024 年佔據主導地位。類器官服務市場成長的主要驅動力包括慢性疾病和病毒感染的盛行率上升、類器官模型的商業化、研發活動的增加以及幹細胞研究的進步。

市場區隔分析

北美類器官服務市場可根據類型、應用和來源進行細分：

依類型：市場包括各種類器官類型，如腸、肝、胃、胰臟、肺、腦、腎等。預計腸道類器官將在2024年佔據最大的市場佔有率。
依應用分類：應用分為發育生物學疾病、傳染病病理學、再生醫學、藥物毒性和療效測試、藥物發現和個人化醫療等。預計發育生物學疾病領域將在2024年引領市場。
依來源：市場分為多能幹細胞和器官特異性成體幹細胞，預計多能幹細胞將在 2024 年佔據主導地位。

市場展望

類器官正成為研究人員和藥物開發者的必備工具，為識別有前景的候選藥物並預測其療效提供了更有效率、更精準的方法。能夠創造患者來源的類器官，為個人化藥物篩選帶來了令人興奮的機會。與傳統的2D細胞培養不同，類器官複製了人體器官的複雜性，包括其細胞組成、結構和功能，從而能夠更準確地預測藥物反應。這種能力使研究人員能夠更有信心地識別潛在的候選藥物，從而降低臨床試驗中代價高昂的失敗風險。

由於對創新篩選服務的需求不斷成長，類器官服務市場正在快速擴張。透過利用源自患者細胞的類器官，研究人員可以根據個別反應客製化藥物測試，從而透過個人化方法提高治療成功率。高通量篩選和自動化影像分析等先進技術的整合，進一步提升了類器官篩選服務的效能。這種結合使研究人員能夠有效地測試多種藥物化合物，更準確地分析結果，並加快藥物研發進程。個人化醫療的興起和對更快藥物開發的需求推動了全球對創新篩選服務的重視，這推動了北美類器官服務市場的成長。

2024年1月，HUB Organoids推出了IntegriGut Screen，這是一項創新的篩檢服務，利用發炎性腸道疾病 (IBD) 患者的類器官單層細胞。該服務提供了高品質的人體上皮屏障功能資料，有助於開發新的IBD療法。

國家洞察

北美類器官服務市場主要由美國、加拿大和墨西哥組成，其中美國在2024年佔據最大市場佔有率。美國類器官服務市場的公司正專注於有機成長策略，以提升其市場佔有率。例如，2023年2月，Molecular Devices, LLC和HUB Organoids宣佈建立策略夥伴關係，旨在推動下一代3D生物學技術，從而顯著降低從臨床前到臨床階段的藥物損耗率。

日益增多的研發活動，以及日益成長的組織工程和器官移植需求，正在推動美國類器官服務市場的發展。類器官有望突破生物醫學研究中先前面臨的諸多限制，例如深入了解人類發育過程、創建精準的疾病模型以及生成用於再生醫學的患者匹配組織。研究經費和創投也在推動人類類器官發展方面發揮了至關重要的作用。例如，美國國家科學基金會資助的一個合作計畫價值約150萬美元，旨在增強腦類器官的發育過程，並提高研究人員最終產品的一致性和可靠性。

公司簡介

北美類器官服務市場的關鍵參與者包括 CUSABIO TECHNOLOGY LLC、Cyprio、Eurofins Scientific SE、HUB Organoids BV、InnoSer、InSphero、LABTOO、Molecular Devices, LLC、Oncodesign Services 和 Sino Biological Inc. 這些公司正在採用擴張、產品創新和併購等各種市場佔有率來增強其產品。

The market is divided into three primary regions: the United States, Canada, and Mexico, with the US anticipated to dominate the market share in 2024. Key drivers of growth in the organoid services market include the rising prevalence of chronic diseases and viral infections, the commercialization of organoid models, increased research and development activities, and advancements in stem cell research.

Market Segmentation Analysis

The North America organoid services market can be segmented based on type, application, and source:

By Type: The market includes various organoid types such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment is expected to hold the largest market share in 2024.
By Application: Applications are categorized into developmental biology disease, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is projected to lead the market in 2024.
By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells expected to dominate in 2024.

Market Outlook

Organoids are becoming essential tools for researchers and pharmaceutical developers, offering more efficient and precise methods for identifying promising drug candidates and predicting their effectiveness. The ability to create patient-derived organoids presents exciting opportunities for personalized drug screening. Unlike traditional 2D cell cultures, organoids replicate the complexity of human organs, including their cellular makeup, structure, and function, which leads to more accurate drug response predictions. This capability allows researchers to identify potential drug candidates with greater confidence, reducing the risk of costly failures in clinical trials.

The organoid services market is experiencing rapid expansion due to the increasing demand for innovative screening services. By utilizing organoids derived from patients' cells, researchers can customize drug testing to individual responses, enhancing the chances of successful treatments through personalized approaches. The integration of advanced technologies, such as high-throughput screening and automated image analysis, further boosts the effectiveness of organoid screening services. This combination allows researchers to efficiently test numerous drug compounds, analyze results with greater accuracy, and expedite the drug discovery process. The global emphasis on innovative screening services, driven by the rise of personalized medicine and the need for faster drug development, supports the growth of the North America organoid services market.

In January 2024, HUB Organoids launched the IntegriGut Screen, a novel screening service that utilizes patient-derived organoid monolayers from inflammatory bowel disease (IBD) patients. This service provides high-quality human data on epithelial barrier function, facilitating the development of new therapies for IBD.

Country Insights

The North America organoid services market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2024. Companies in the US organoid services market are focusing on organic growth strategies to enhance their market presence. For instance, in February 2023, Molecular Devices, LLC and HUB Organoids announced a strategic partnership aimed at advancing next-generation 3D biology technologies to significantly reduce drug attrition rates from preclinical to clinical stages.

The increasing research and development activities, along with a growing demand for tissue engineering and organ transplantation, are propelling the organoid services market in the US. Organoids have the potential to address several limitations previously faced in biomedical research, such as gaining insights into human development, creating accurate disease models, and generating patient-matched tissues for regenerative medicine. Research funding and venture capital investments have also played a crucial role in advancing human organoid development. For example, a collaborative project funded by the National Science Foundation, valued at approximately US$ 1.5 million, aims to enhance brain organoid development processes and improve the consistency and reliability of end products for researchers.

Company Profiles

Key players in the North America organoid services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Organoids Services Market Landscape

4.1 PEST Analysis

5. North America Organoids Services Market - Key Market Dynamics

5.1 North America Organoids Services Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Demand for Innovative Drug Screening Services
- 5.2.2 Surge in Popularity of Personalized Drugs
5.3 Market Restraints
- 5.3.1 Dearth of Skilled Professionals
5.4 Market Opportunities
- 5.4.1 Increasing Key Developments
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence
5.6 Impact of Drivers and Restraints:

6. North America Organoids Services Market - Analysis

6.1 North America Organoids Services Market Revenue (US$ Million), 2021-2031
6.2 North America Organoids Services Market Forecast Analysis

7. North America Organoids Services Market Analysis - by Type

7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Organoids Services Market Analysis - by Application

8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery and Personalized Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Organoids Services Market Analysis - by Source

9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Organoids Services Market - Country Analysis

10.1 North America
- 10.1.1 North America Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 North America Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 United States: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 United States: North America Organoids Services Market Share - by Type
    - 10.1.1.2.2 United States: North America Organoids Services Market Share - by Application
    - 10.1.1.2.3 United States: North America Organoids Services Market Share - by Source
  - 10.1.1.3 Canada: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Canada: North America Organoids Services Market Share - by Type
    - 10.1.1.3.2 Canada: North America Organoids Services Market Share - by Application
    - 10.1.1.3.3 Canada: North America Organoids Services Market Share - by Source
  - 10.1.1.4 Mexico: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Mexico: North America Organoids Services Market Share - by Type
    - 10.1.1.4.2 Mexico: North America Organoids Services Market Share - by Application
    - 10.1.1.4.3 Mexico: North America Organoids Services Market Share - by Source

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organoids Services Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Sino Biological Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Eurofins Scientific SE
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Molecular Devices, LLC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 InSphero
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Cyprio
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 InnoSer
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 LABTOO
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 CUSABIO TECHNOLOGY LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Oncodesign Services
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Organoids Services Market Segmentation
Table 2. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
Table 4. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
Table 6. North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 8. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 9. United States: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 10. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 11. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 12. Canada: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 13. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 15. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
Table 16. Recent Organic Growth Strategies in Organoids Services Market
Table 17. Recent Inorganic Growth Strategies in the Organoids Services Market
Table 18. Glossary of Terms, Organoids Services Market

List Of Figures

Figure 1. North America Organoids Services Market Segmentation - Country
Figure 2. PEST Analysis
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. North America Organoids Services Market Revenue (US$ Million), 2021-2031
Figure 3. North America Organoids Services Market Share (%) - by Type (2023 and 2031)
Figure 4. Intestine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 5. Liver: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 6. Stomach: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 7. Pancreas: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Lung: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Brain: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Kidney: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. North America Organoids Services Market Share (%) - by Application (2023 and 2031)
Figure 13. Developmental Biology Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Pathology of Infectious Disease: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Regenerative Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Drug Toxicity and Efficacy Testing: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Drug Discovery and Personalized Medicine: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. Others: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. North America Organoids Services Market Share (%) - by Source (2023 and 2031)
Figure 20. Pluripotent Stem Cells: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Organ Specific Adult Stem Cell: North America Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 22. North America Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. United States: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 24. Canada: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 25. Mexico: North America Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 26. Growth Strategies in Organoids Services Market